These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7870368)

  • 21. Morbidity and mortality on maintenance haemodialysis.
    Locatelli F; Del Vecchio L; Manzoni C
    Contrib Nephrol; 1998; 124():166-89; discussion 190-201. PubMed ID: 9761980
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemodialysis cataract.
    Angra SK; Goyal JL
    Indian J Ophthalmol; 1987; 35(2):82-3. PubMed ID: 3450624
    [No Abstract]   [Full Text] [Related]  

  • 23. Peritoneal dialysis therapy for patients with liver and renal failure with ascites.
    Poulos AM; Howard L; Eisele G; Rodgers JB
    Am J Gastroenterol; 1993 Jan; 88(1):109-12. PubMed ID: 8420247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephrogenic ascites: a poorly understood syndrome: a case report].
    Hellara O; Hammami A; Ben Chaabène N; Aloui S; Melki W; Loghmari H; Ben Mansour W; Safer L; Zakhama A; Noomen F; Bdioui F; Saffar H
    Tunis Med; 2013 Nov; 91(11):671-3. PubMed ID: 24343494
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis.
    Schwenk MH; Jumani AQ; Rosenberg CR; Kulogowski JE; Charytan C; Spinowitz BS
    Pharmacotherapy; 1998; 18(3):627-30. PubMed ID: 9620114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chylous ascites and chylothorax due to constrictive pericarditis in a patient undergoing haemodialysis.
    Riza Altiparmak M; Avsar S; Yanik S
    Neth J Med; 2004 Feb; 62(2):59-61. PubMed ID: 15127833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calciphylaxis in a haemodialysis patient: functional protein S deficiency?
    Perez-Mijares R; Guzman-Zamudio JL; Payan-Lopez J; Rodriguez-Fernandez A; Gomez-Fernandez P; Almaraz-Jimenez M
    Nephrol Dial Transplant; 1996 Sep; 11(9):1856-9. PubMed ID: 8918640
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic arthropathy and rectal bleeding in a long-term haemodialysis patient.
    Zingraff J; Droz D; Touam M; Voisin MC; Drüeke T
    Nephrol Dial Transplant; 1995 Nov; 10(11):2153-5. PubMed ID: 8643191
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: a real clinical entity?
    Tarng DC; Huang TP; Chen TW; Fan CY; Chang JG
    Nephrol Dial Transplant; 1996 Sep; 11(9):1893-5. PubMed ID: 8918654
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ascites in hemodialysis].
    Vidal C; Morlans M; Cuevas J; Pelegrí A; Serra A; Olmos A
    Med Clin (Barc); 1984 Mar; 82(10):438-41. PubMed ID: 6717128
    [No Abstract]   [Full Text] [Related]  

  • 32. Osmotic disequilibrium causing ascites during chronic hemodialysis.
    Fajardo B; Gonzalez G; Tannenberg AM
    ASAIO Trans; 1988; 34(3):617-9. PubMed ID: 3196574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of hypercalcaemia in haemodialysis patients.
    Pascual N; Andrea C; Zaleski M; Hernandez J; Goicoechea M
    EDTNA ERCA J; 1997; 23(3):48-50. PubMed ID: 9664010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients.
    Dhondt AW; Vanholder RC; Ringoir SM
    Nephrol Dial Transplant; 1995 Nov; 10(11):2107-9. PubMed ID: 8643177
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascular calcification in chronic haemodialysis patients.
    Susalit E
    Acta Med Indones; 2008 Oct; 40(4):177. PubMed ID: 19530366
    [No Abstract]   [Full Text] [Related]  

  • 36. ACE inhibitors and renoprotection.
    Peterson K
    J Fam Pract; 1996 May; 42(5):453. PubMed ID: 8642355
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemorheological changes in patients undergoing haemodialysis for chronic renal failure and retinal ischaemia.
    Elgohary M
    Eye (Lond); 2004 Sep; 18(9):958-9. PubMed ID: 15044936
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of tunnelled haemodialysis catheters at the start of haemodialysis--success rates and definition of infection.
    Aslam N; Lambie M; Ayub V; Stein A
    Nephrol Dial Transplant; 2007 Jun; 22(6):1799-800. PubMed ID: 17389620
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemodialysis in infants.
    Vaartjes H; Frankhuisen J; Veuger A
    EDTNA ERCA J; 1996; 22(4):24-5, 28. PubMed ID: 10723344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and cost of haemodialysis in Jordan.
    Batieha A; Abdallah S; Maghaireh M; Awad Z; Al-Akash N; Batieneh A; Ajlouni KA
    East Mediterr Health J; 2007; 13(3):654-63. PubMed ID: 17687839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.